Stock Price
7.44
Daily Change
-0.31 -3.94%
Monthly
22.09%
Yearly
33.72%
Q1 Forecast
7.45

Ardelyx reported $7.12M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 7.12M 19.62M Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Sanofi EUR 3.74B 2.23B Sep/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
United Therapeutics USD 389.3M 112.4M Sep/2025